About Gamma Vaccines
Gamma Vaccines is a company based in Canberra (Australia) founded in 2009. Gamma Vaccines has raised $551.69 thousand across 1 funding round from investors including SOHO Global Health. Gamma Vaccines offers products and services including Broad Spectrum Vaccines and NDV Vaccine. Gamma Vaccines operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Serum Institute of India, Vaxcyte and Generate Biomedicines, among others.
- Headquarter Canberra, Australia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gamma Vaccines Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$551.69 K (USD)
in 1 rounds
-
Latest Funding Round
$551.69 K (USD), Seed
Dec 02, 2009
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gamma Vaccines
Gamma Vaccines offers a comprehensive portfolio of products and services, including Broad Spectrum Vaccines and NDV Vaccine.
Vaccines targeting various human and animal viruses for disease prevention.
Vaccine for Newcastle disease virus in animals and poultry.
Funding Insights of Gamma Vaccines
Gamma Vaccines has successfully raised a total of $551.69K through 1 strategic funding round. The most recent funding activity was a Seed round of $551.69 thousand completed in December 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Gamma Vaccines
Gamma Vaccines has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SOHO Global Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SOHO Global Health is engaged in herbal-based medicine development.
|
Locked | Locked | Locked |
Investor details for Gamma Vaccines
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gamma Vaccines
Investment portfolio details for Gamma Vaccines
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gamma Vaccines
Detailed financials for Gamma Vaccines
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gamma Vaccines Comparisons
Peer comparison for Gamma Vaccines
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gamma Vaccines
Gamma Vaccines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Serum Institute of India, Vaxcyte and Generate Biomedicines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
Detailed competitors of Gamma Vaccines
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gamma Vaccines
Complete news archive for Gamma Vaccines
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gamma Vaccines
Gamma Vaccines was founded in 2009.
Gamma Vaccines is headquartered in Canberra, Australia. It is registered at Canberra, Australian Capital Territory, Australia.
Gamma Vaccines is a funded company, having raised a total of $551.69K across 1 funding round to date.
Gamma Vaccines was founded in 2009 in Canberra, Australia, within the biotechnology sector. Focus is placed on developing broad-spectrum, intranasal vaccines targeting human and avian influenza viruses. Inactivated virus strains are prepared using gamma irradiation to maintain protein structures, enabling intranasal administration. Potential exists for stockpiling as a universal flu vaccine for pandemic response. Additional research is conducted on vaccines for avian influenza in poultry and bacterial pneumonia prevention.
Gamma Vaccines's top competitors include Moderna, Adaptive Biotechnologies and Vaxcyte.
Gamma Vaccines offers Broad Spectrum Vaccines and NDV Vaccine.
Gamma Vaccines has 1 investor. Key investors include SOHO Global Health.